Jens Juul Holst

Publikation

Publikationer pr. år 1977 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020

• 1337 Tidsskriftartikel
• 30 Bidrag til bog/antologi
• 26 Konferenceabstrakt i tidsskrift
• 26 Review
• 53 Mere
  • 11 Letter
  • 10 Konferenceartikel
  • 8 Konferencebidrag i proceedings
  • 7 Kommentar/debat
  • 3 Paper
  • 2 Encyclopædiartikel
  • 2 Konferenceabstrakt til konference
  • 2 Poster
  • 2 Leder
  • 1 Konferenceabstrakt i proceedings
  • 1 Bidrag til rapport
  • 1 Bidrag til avis - Kommentar/debat
  • 1 Bidrag til avis - Kronik
  • 1 Udgivelser på nettet - Net-publikation
  • 1 Patent

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2014

  Stimulation of intestinal growth and function with DPP-IV inhibition in a mouse short bowel syndrome model

  Sueyoshi, R., Ignatoski, K. M. W., Okawada, M., Hartmann, B., Holst, J. J. & Teitelbaum, D. H., 15 aug. 2014, I: American Journal of Physiology: Gastrointestinal and Liver Physiology. 307, 4, s. G410-19 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Short Bowel Syndrome 100%
  • Glucagon-Like Peptide 2 86%
  • Glucagon-Like Peptide-2 Receptor 67%
  • Epithelial Cells 39%
  • MK0626 39%
  16 Citationer (Scopus)

• Targeting the intestinal L-cell for obesity and type 2 diabetes treatment

  Albrechtsen, N. J. W., Kuhre, R. E., Deacon, C. F. & Holst, J. J., 1 jan. 2014, I: Expert Review of Endocrinology & Metabolism. 9, 1, s. 61-72 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Enteroendocrine Cells 100%
  • Glucagon-Like Peptide 1 82%
  • Type 2 Diabetes Mellitus 52%
  • Obesity 48%
  • Appetite Regulation 37%
  22 Citationer (Scopus)

• The authors reply

  Idorn, T., Knop, F. K., Jørgensen, M., Holst, J. J., Hornum, M. & Feldt-Rasmussen, B., jan. 2014, I: Kidney International. 85, 1, s. 212-3 2 s.

  Publikation: Bidrag til tidsskrift › Letter › peer review

• The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects

  Rhee, N. A., Østoft, S. H., Holst, J. J., Deacon, C., Vilsbøll, T. & Knop, F. K., 1 sep. 2014, I: European Journal of Endocrinology. 171, 3, s. 353-362 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Dipeptidyl Peptidase 4 100%
  • Incretins 96%
  • Psychological Inhibition 60%
  • Healthy Volunteers 49%
  • Glucose 46%
  19 Citationer (Scopus)

• The incretin effect does not differ in trained and untrained, young, healthy men

  Lund, M. T., Dalby, S., Hartmann, B., Helge, J. W., Holst, J. J. & Dela, F., mar. 2014, I: Acta Physiologica. 210, 3, s. 565-72 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Incretins 100%
  • Glucose 48%
  • Insulin 28%
  • Glucagon-Like Peptide 1 27%
  • Insulin Secretion 23%
  9 Citationer (Scopus)

• The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance

  van Poppel, P. C. M., van Asseldonk, E. J. P., Holst, J. J., Vilsbøll, T., Netea, M. G. & Tack, C. J., 1 dec. 2014, I: Diabetes, Obesity and Metabolism. 16, 12, s. 1269-73 5 s.

  Publikation: Bidrag til tidsskrift › Letter › peer review

  • Interleukin 1 Receptor Antagonist Protein 100%
  • Interleukin-1 Receptors 87%
  • Glucose Intolerance 78%
  • Insulin Secretion 73%
  • Interleukin-1 36%
  25 Citationer (Scopus)

• The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo

  Panaro, B. L., Tough, I. R., Engelstoft, M. S., Matthews, R. T., Digby, G. J., Møller, C. L., Svendsen, B., Gribble, F., Reimann, F., Holst, J. J., Holst, B., Schwartz, T. W., Cox, H. M. & Cone, R. D., 2 dec. 2014, I: Cell Metabolism. 20, 6, s. 1018-29 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Receptor, Melanocortin, Type 4 100%
  • Enteroendocrine Cells 96%
  • Peptide YY 96%
  • L Cells 89%
  • Glucagon-Like Peptide 1 79%
  95 Citationer (Scopus)

• Therapies for inter-relating diabetes and obesity - GLP-1 and obesity

  Iepsen, E. P. W., Torekov, S. S. & Holst, J. J., 1 dec. 2014, I: Expert Opinion on Pharmacotherapy. 15, 17, s. 2487-500 14 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Incretins 63%
  • Obesity 59%
  • Anti-Obesity Agents 34%
  • Glucagon-Like Peptide-1 Receptor 31%
  26 Citationer (Scopus)

• The use of double-balloon enteroscopy in retrieving mucosal biopsies from the entire human gastrointestinal tract

  Rhee, N. A., Vilmann, P., Hassan, H., Hendel, J. W., Holst, J. J., Vilsbøll, T. & Knop, F. K., sep. 2014, I: Scandinavian Journal of Gastroenterology. 49, 9, s. 1143-1149 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Double-Balloon Enteroscopy 100%
  • Gastrointestinal Tract 55%
  • Type 2 Diabetes Mellitus 47%
  • Healthy Volunteers 42%
  • Biopsy 38%
  3 Citationer (Scopus)

• Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report

  Knop, F. K., Lund, A., Madsbad, S., Holst, J. J., Krarup, T. & Vilsbøll, T., 31 maj 2014, I: BMC Research Notes. 7, s. 1-6 6 s., 326.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Insulinotropic 100%
  • Glucagon-Like Peptide 1 94%
  • C-Peptide 73%
  • Insulin Derivative 61%
  • Research Subjects 60%
  1 Citationer (Scopus)
• 2013

  Acute differential effects of dietary protein quality on postprandial lipemia in obese non-diabetic subjects

  Holmer-Jensen, J., Mortensen, L. S., Astrup, A., de Vrese, M., Holst, J. J., Thomsen, C. & Hermansen, K., jan. 2013, I: Nutrition Research. 33, 1, s. 34-40 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Whey Proteins 100%
  • Dietary Proteins 89%
  • Gadiformes 87%
  • Glutens 71%
  • Hyperlipidemias 71%
  42 Citationer (Scopus)

• Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study

  Madsen, K. B., Askov-Hansen, C., Naimi, R. M., Brandt, C. F., Hartmann, B., Holst, J. J., Mortensen, P. B. & Jeppesen, P. B., 10 jun. 2013, I: Regulatory Peptides. 184, 10, s. 30-9 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Glucagon-Like Peptide 1 78%
  • Short Bowel Syndrome 67%
  • Intestinal Absorption 56%
  • Placebos 34%
  50 Citationer (Scopus)

• A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients

  Naimi, R. M., Madsen, K. B., Askov-Hansen, C., Brandt, C. F., Hartmann, B., Holst, J. J., Mortensen, P. B. & Jeppesen, P. B., 10 jun. 2013, I: Regulatory Peptides. 184, 10, s. 47-53 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Short Bowel Syndrome 67%
  • Meals 44%
  • Peptide 28%
  • Injections 28%
  6 Citationer (Scopus)

• A pilot study examining the relationship among Crohn disease activity, glucagon-like peptide-2 signalling and intestinal function in pediatric patients

  Sigalet, D. L., Kravarusic, D., Butzner, D., Hartmann, B., Holst, J. J. & Meddings, J., okt. 2013, I: Canadian Journal of Gastroenterology. 27, 10, s. 587-92 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Crohn Disease 60%
  • Pediatrics 40%
  • Ileal Diseases 19%
  • Permeability 16%
  9 Citationer (Scopus)

• Appetite regulation in overweight, sedentary men after different amounts of endurance exercise: a randomized controlled trial

  Larsen, M. R., Reichkendler, M. H., Auerbach, P., Toräng, S., Gram, A. S., Ploug, T., Holst, J. J., Sjödin, A. & Stallknecht, B., 1 dec. 2013, I: Journal of Applied Physiology. 115, 11, s. 1599-1609 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Appetite Regulation 100%
  • Overweight 66%
  • Randomized Controlled Trials 50%
  • Exercise 48%
  • Fasting 38%
  21 Citationer (Scopus)

• A single supplement of a standardised bilberry (Vaccinium myrtillus L.) extract (36 % wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle

  Hoggard, N., Cruickshank, M., Moar, K-M., Bestwick, C., Holst, J. J., Russell, W. & Horgan, G., 2013, I: Journal of Nutritional Science. 2, s. e22

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Vaccinium myrtillus extract 100%
  • Vaccinium myrtillus 82%
  • bilberries 69%
  • Anthocyanins 66%
  • noninsulin-dependent diabetes mellitus 62%
  51 Citationer (Scopus)

• Bile acids induce glucagon-like peptide 2 secretion with limited effects on intestinal adaptation in early weaned pigs

  Ipharraguerre, I. R., Tedó, G., Menoyo, D., de Diego Cabero, N., Holst, J. J., Nofrarías, M., Mereu, A. & Burrin, D. G., 1 dec. 2013, I: Journal of Nutrition. 143, 12, s. 1899-905 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Bile Acids and Salts 65%
  • Centers for Disease Control and Prevention (U.S.) 64%
  • Swine 50%
  • Weaning 27%
  19 Citationer (Scopus)

• Characterization of oral and intravenous glucose handling in truncally vagotomised subjects with pyloroplasty

  Plamboeck, A., Veedfald, S., Deacon, C., Hartmann, B., Wettergren, A., Svendsen, L. B., Meisner, S., Hovendal, C., Knop, F. K., Vilsbøll, T. & Holst, J. J., aug. 2013, I: European Journal of Endocrinology. 169, s. 187-201 14 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucose 100%
  • Glucagon-Like Peptide 1 82%
  • Glucose Tolerance Test 71%
  • Glucagon 55%
  • Incretins 45%
  42 Citationer (Scopus)

• Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings

  Holst, J. J. & Vilsbøll, T., jan. 2013, I: Diabetes, Obesity and Metabolism. 15, 1, s. 3-14 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide-1 Receptor 100%
  • Insulin 52%
  • Hypoglycemia 22%
  • Therapeutics 12%
  • Clinical Studies 10%
  60 Citationer (Scopus)

• Contribution of gastroenteropancreatic appetite hormones to protein-induced satiety

  Sparre, A. B., Ritz, C., Sørensen, M. Q., Holst, J. J., Rehfeld, J. F. & Astrup, A., 1 maj 2013, I: American Journal of Clinical Nutrition. 97, 5, s. 980-989 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Appetite 100%
  • Hormones 67%
  • peptide YY (3-36) 41%
  • Glucagon-Like Peptide 1 37%
  • Proteins 35%
  113 Citationer (Scopus)

• Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol

  Pedersen, L. R., Olsen, R. H., Frederiksen, M., Astrup, A., Chabanova, E., Hasbak, P., Holst, J. J., Kjær, A., Newman, J. W., Walzem, R., Wisløff, U., Sajadieh, A., Haugaard, S. B. & Prescott, E., 19 nov. 2013, I: B M C Cardiovascular Disorders. 13, 1, 8 s., 106.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Overweight 100%
  • Coronary Artery Disease 93%
  • Weight Loss 92%
  • Diet 77%
  • Exercise 58%
  12 Citationer (Scopus)

  2574 Downloads (Pure)

• Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety

  Deacon, C. F. & Holst, J. J., okt. 2013, I: Expert Opinion on Pharmacotherapy. 14, 15, s. 2047-58 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Dipeptidyl-Peptidase IV Inhibitors 100%
  • Type 2 Diabetes Mellitus 56%
  • Safety 44%
  • Gastrointestinal Hormones 26%
  • Dipeptidyl Peptidase 4 25%
  91 Citationer (Scopus)

• Early growth and postprandial appetite regulatory hormone responses

  Perälä, M-M., Kajantie, E., Valsta, L. M., Holst, J. J., Leiviskä, J. & Eriksson, J. G., 14 nov. 2013, I: British Journal of Nutrition. 110, 09, s. 1-10 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Appetite 100%
  • Meals 86%
  • Hormones 67%
  • Growth 48%
  • Whey 32%
  9 Citationer (Scopus)

• Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure

  Askov-Hansen, C., Jeppesen, P. B., Lund, P., Hartmann, B., Holst, J. J. & Henriksen, D. B., 10 feb. 2013, I: Regulatory Peptides. 181, s. 4-8 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Sitagliptin 80%
  • Sitagliptin Phosphate 52%
  • Subcutaneous Injections 51%
  • Bone Resorption 50%
  16 Citationer (Scopus)

• Effect of tumor necrosis factor-alpha infusion on the incretin effect in healthy volunteers

  Nielsen, S. T., Lehrskov-Schmidt, L., Krogh-Madsen, R., Solomon, T., Lehrskov-Schmidt, L., Holst, J. J. & Møller, K., 31 jul. 2013, I: Diabetes - Metabolism: Research and Reviews (Online). 29, 8, s. 655-663 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Incretins 100%
  • Vascular Resistance 72%
  • Insulin Resistance 63%
  • Tumor Necrosis Factor-alpha 54%
  • Healthy Volunteers 51%
  19 Citationer (Scopus)

• Effects of a meal rich in medium-chain saturated fat on postprandial lipemia in relatives of type 2 diabetics

  Pietraszek, A., Hermansen, K., Pedersen, S. B., Langdahl, B. L., Holst, J. J. & Gregersen, S., jul. 2013, I: Nutrition. 29, 7-8, s. 1000-1006 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Hyperlipidemias 100%
  • Meals 89%
  • Fats 74%
  • Fatty Acids 53%
  • Adipose Tissue 31%
  3 Citationer (Scopus)

• Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals

  Jacobsen, S. H., Bojsen-Møller, K. N., Dirksen, C., Jørgensen, N. B., Clausen, T. R., Wulff, B. S., Kristiansen, V. B., Worm, D., Hansen, D. L., Holst, J. J., van Hall, G. & Madsbad, S., okt. 2013, I: Diabetologia. 56, 10, s. 2250-4 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gastric Bypass 100%
  • Meals 78%
  • Glucose 54%
  • Lipolysis 10%
  • Insulin 6%
  72 Citationer (Scopus)

• Effects of oleic acid and olive oil on gastric emptying, gut hormone secretion and appetite in lean and overweight or obese males

  Damgaard, M., Graff, J., Fuglsang, S., Holst, J. J., Rehfeld, J. F. & Madsen, J. L., feb. 2013, I: e - S P E N Journal. 8, 1, s. e8-e14 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Olive Oil 100%
  • Oleic Acid 93%
  • Gastric Emptying 91%
  • Appetite 83%
  • Energy Intake 80%
  8 Citationer (Scopus)

• Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery

  Holst, J. J., dec. 2013, I: Current Opinion in Pharmacology. 13, 6, s. 983-8 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gastrointestinal Hormone 100%
  • Glucagon-Like Peptide 1 91%
  • Bariatric Surgery 64%
  • Hormone 46%
  • Hormones 40%
  77 Citationer (Scopus)

• Evidence for paracrine/autocrine regulation of GLP-1-producing cells

  Kappe, C., Zhang, Q., Holst, J. J., Nyström, T. & Sjöholm, A., 15 nov. 2013, I: A J P: Cell Physiology (Online). 305, 10, s. C1041-9

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Insulin 38%
  • Exenatide 29%
  • Palmitates 26%
  • L Cells 18%
  17 Citationer (Scopus)

• Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass

  Dirksen, C., Bojsen-Møller, K. N., Jørgensen, N. B., Jacobsen, S. H., Kristiansen, V. B., Naver, L. S., Hansen, D. L., Worm, D., Holst, J. J. & Madsbad, S., dec. 2013, I: Diabetologia. 56, 12, s. 2679-2687

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Gastric Bypass 97%
  • Insulin 58%
  • Glucose 53%
  • Glucagon 29%
  51 Citationer (Scopus)

• Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass

  Dirksen, C., Damgaard, M., Bojsen-Møller, K. N., Jørgensen, N. B., Kielgast, U., Jacobsen, S. H., Naver, L. S., Worm, D., Holst, J. J., Madsbad, S., Hansen, D. L. & Madsen, J. L., apr. 2013, I: Neurogastroenterology and Motility. 25, 4, s. 346-e255 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gastric Bypass 100%
  • peptide YY (3-36) 75%
  • Hormones 61%
  • Glucagon-Like Peptide 1 51%
  • Glucagon-Like Peptides 22%
  113 Citationer (Scopus)

• Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease

  Idorn, T., Knop, F. K., Jørgensen, M., Holst, J. J., Hornum, M. & Feldt-Rasmussen, B., maj 2013, I: Kidney International. 83, 5, s. 915-23 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Chronic Kidney Failure 100%
  • Incretins 88%
  • Glucose 64%
  • Glucagon 35%
  • Hormones 24%
  22 Citationer (Scopus)

• GLP-2 Delays But Does Not Prevent the Onset of Necrotizing Enterocolitis in Preterm Pigs

  Benight, N. M., Stoll, B., Olutoye, O. O., Holst, J. J. & Burrin, D. G., jun. 2013, I: Journal of Pediatric Gastroenterology and Nutrition. 56, 6, s. 623-30 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Necrotizing Enterocolitis 77%
  • Swine 50%
  • Glucagon-Like Peptides 13%
  • Serum Amyloid A Protein 11%
  13 Citationer (Scopus)

• Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men

  Skov, J., Dejgaard, A., Frøkiær, J., Holst, J. J., Jonassen, T., Rittig, S. & Christiansen, J. S., apr. 2013, I: Journal of Clinical Endocrinology and Metabolism. 98, 4, s. E664-71 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Hemodynamic 92%
  • Renin-Angiotensin System 65%
  • Hemodynamics 46%
  • Renal Plasma Flow 37%
  107 Citationer (Scopus)

• Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain

  Gejl, M., Lerche, S., Egefjord, L., Brock, B., Møller, N., Vang, K., Rodell, A., Bibby, B. M., Holst, J. J., Rungby, J. & Gjedde, A., 2013, I: Frontiers in Neuroenergetics. 5, s. 1-9 10 s., 2.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Hexokinase 100%
  • Glucagon-Like Peptide 1 92%
  • Human Activities 79%
  • Blood Glucose 65%
  • Glucose 49%
  20 Citationer (Scopus)

• Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis

  Kissow, H., Hartmann, B., Holst, J. J. & Poulsen, S. S., dec. 2013, I: Gut.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Mucositis 100%
  • Glucagon-Like Peptide 1 97%
  • Glucagon-Like Peptide 2 78%
  • Drug Therapy 48%
  • exendin (9-39) 41%
  32 Citationer (Scopus)

• Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates

  Vegge, A., Thymann, T., Lund, P., Stoll, B., Bering, S. B., Hartmann, B., Jelsing, J., Qvist, N., Burrin, D. G., Jeppesen, P. B., Holst, J. J. & Sangild, P. T., 8 maj 2013, I: American Journal of Physiology: Gastrointestinal and Liver Physiology. 305, 4, s. G277-G285 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Short Bowel Syndrome 53%
  • Newborn Infant 48%
  • Swine 37%
  • Jejunostomy 21%
  37 Citationer (Scopus)

• Glucagon-like peptides 1 and 2, enteroglucagon, glicentin and oxyntomodulin

  Holst, J. J., Deacon, C. F., Hartmann, B. & Pedersen, J., 2013, Handbook of Biologically Active Peptides . Kastin, AJ. (red.). 2 udg. Elsevier, s. 1241-1250 10 s.

  Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Undervisning

• Glucose metabolism is altered after loss of L cells and α-cells but not influenced by loss of K cells

  Pedersen, J., Ugleholdt, R. K., Jørgensen, S. M., Windeløv, J. A., Grunddal, K. V., Schwartz, T. W., Füchtbauer, E-M., Poulsen, S. S., Holst, P. J. & Holst, J. J., 1 jan. 2013, I: American Journal of Physiology: Endocrinology and Metabolism. 304, 1, s. E60-73 14 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • L Cells 100%
  • Glucose 47%
  • Peptides 26%
  • Glucagon 18%
  • Glucagon-Like Peptide 1 13%
  32 Citationer (Scopus)

• Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass

  Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Kielgast, U., Jacobsen, S. H., Clausen, T. R., Worm, D., Hartmann, B., Rehfeld, J. F., Damgaard, M., Madsen, J. L., Madsbad, S., Holst, J. J. & Hansen, D. L., nov. 2013, I: International Journal of Obesity. 37, s. 1452-1459 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gastric Bypass 100%
  • Energy Metabolism 78%
  • Glucagon-Like Peptide 1 76%
  • Weight Loss 71%
  • Hormones 61%
  149 Citationer (Scopus)

• Gut microbiota may have influence on glucose and lipid metabolism.

  Mikkelsen, K. H., Nielsen, M. F., Tvede, M., Hansen, T., Pedersen, O. B., Holst, J. J., Vilsbøll, T. & Knop, F. K., 11 nov. 2013, I: Ugeskrift for Laeger. 175, 46, s. 2785-2788 4 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gastrointestinal Microbiome 100%
  • Lipid Metabolism 97%
  • Glucose 63%
  • Fecal Microbiota Transplantation 48%
  • Obesity 47%
  1 Citationer (Scopus)

• Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques

  Faurschou, A., Pedersen, J., Gyldenløve, M., Poulsen, S. S., Holst, J. J., Thyssen, J. P., Zachariae, C., Vilsbøll, T., Skov, L. & Knop, F. K., feb. 2013, I: Experimental Dermatology. 22, 2, s. 150-2 3 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Glucagon-Like Peptide-1 Receptor 81%
  • Psoriasis 62%
  • Agonist 60%
  • Skin 29%
  17 Citationer (Scopus)

• Increased Hepatic Insulin Clearance After Roux-en-Y Gastric Bypass

  Bojsen-Møller, K. N., Dirksen, C., Jørgensen, N. B., Jacobsen, S. H., Hansen, D. L., Worm, D., Naver, L., Kristiansen, V. B., Holst, J. J. & Madsbad, S., jun. 2013, I: Journal of Clinical Endocrinology and Metabolism. 98, 6, s. E1066-E1071 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gastric Bypass 100%
  • Clearance 93%
  • Insulin Derivative 88%
  • Insulin 59%
  • Liver 44%
  57 Citationer (Scopus)

• Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele

  Faerch, K., Pilgaard, K., Knop, F. K., Hansen, T., Pedersen, O., Jørgensen, T. & Holst, J. J., jan. 2013, I: Diabetes, Obesity and Metabolism Online. 15, 1, s. 91-95 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • T Cell Transcription Factor 1 100%
  • Pancreatic Hormones 95%
  • Incretins 82%
  • Alleles 46%
  • Glucose 39%
  18 Citationer (Scopus)

• Incretin hormones and the satiation signal

  Holst, J. J., sep. 2013, I: International journal of obesity (2005). 37, 9, s. 1161-8 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Satiation 100%
  • Incretins 91%
  • Glucagon-Like Peptide 1 82%
  • Hormones 49%
  • Liraglutide 32%
  92 Citationer (Scopus)

• Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: A Randomized Cross-Over Trial

  Kristensen, P. L., Pedersen-Bjergaard, U., Kjær, T. W., Olsen, N. V., Dela, F., Holst, J. J., Faber, J., Tarnow, L. & Thorsteinsson, B., 5 apr. 2013, I: P L o S One. 8, 4, s. 1-8 8 s., e59672.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Diabetes Mellitus 100%
  • Crossover Trial 94%
  • insulin-dependent diabetes mellitus 93%
  • Randomized Trial 85%
  • hypoglycemia 82%
  18 Citationer (Scopus)

• Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?

  van Raalte, D. H., Kwa, K. A. A., van Genugten, R. E., Tushuizen, M. E., Holst, J. J., Deacon, C. F., Karemaker, J. M., Heine, R. J., Mari, A. & Diamant, M., apr. 2013, I: Metabolism. 62, 4, s. 568-577 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Prednisolone 100%
  • Islets of Langerhans 97%
  • Glucocorticoids 88%
  • Glucagon 58%
  • Placebos 38%
  22 Citationer (Scopus)

• Is there a place for incretin therapies in obesity and prediabetes?

  Holst, J. J. & Deacon, C. F., mar. 2013, I: Trends in Endocrinology and Metabolism. 24, 3, s. 145-152 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Incretins 100%
  • Glucagon-Like Peptide-1 Receptor 99%
  • Prediabetic State 99%
  • Obesity 53%
  • Dipeptidyl-Peptidase IV Inhibitors 50%
  27 Citationer (Scopus)

• Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients

  Camastra, S., Muscelli, E., Gastaldelli, A., Holst, J. J., Astiarraga, B., Baldi, S., Nannipieri, M., Ciociaro, D., Anselmino, M., Mari, A. & Ferrannini, E., nov. 2013, I: Diabetes. 62, 11, s. 3709-17 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Bariatric Surgery 100%
  • Meals 80%
  • Glucose 56%
  • Type 2 Diabetes Mellitus 27%
  • Insulin Resistance 22%
  75 Citationer (Scopus)